- Home
- DAWN
DAWN
Day One Biopharmaceuticals Inc.
as 07-04-2025 11:33am EST
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | BRISBANE |
| Market Cap: | N/A | IPO Year: | 2021 |
| Target Price: | $31.57 | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.71 | EPS Growth: | N/A |
| 52 Week Low/High: | $6.08 - $16.76 | Next Earning Date: | 07-29-2025 |
| Revenue: | $161,922,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | 17.98% | Revenue Growth (next year): | 49.50% |
Stock Insider Trading Activity of Day One Biopharmaceuticals Inc. (DAWN)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Dubow Adam | DAWN | GENERAL COUNSEL | May 15 '25 | Sell | $6.26 | 4,552 | $28,485.96 | 47,136 | |
| Bender Jeremy | DAWN | CHIEF EXECUTIVE OFFICER | May 15 '25 | Sell | $6.26 | 13,964 | $87,385.32 | 145,737 | |
| Merendino Lauren | DAWN | Chief Commercial Officer | May 15 '25 | Sell | $6.26 | 3,927 | $24,574.77 | 35,161 | |
| York Charles N II | DAWN | COO, CFO AND SECRETARY | May 15 '25 | Sell | $6.26 | 4,282 | $26,796.33 | 265,231 |
Latest Day One Biopharmaceuticals Inc. News
DAWN Breaking Stock News: Dive into DAWN Ticker-Specific Updates for Smart Investing
GlobeNewswire
a month ago
Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development
GOBankingRates
a month ago
7 Luxury Vehicles Expected To Skyrocket in Price Due To Trump’s Tariffs
GOBankingRates
a month ago
3 International Vacations That Are Cheaper Than an iPhone
GOBankingRates
a month ago
Suze Orman’s 5 Best Tips for Saving Money Even When Living Paycheck to Paycheck
Yahoo Finance
a month ago
This week in Trumponomics: Too bad TACO isn’t true
The Guardian
a month ago
Starmer says Farage would spook the City and give us Truss 2 – he could be right
Yahoo Finance Video
a month ago
AI ecosystem isn't just Nvidia: Unlock it further with this ETF
Benzinga
a month ago
Is Dave Ramsey's Home Buying Advice Realistic For The Average Homeowner?
Compare DAWN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DAWN Day One Biopharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.